Curated News
By: NewsRamp Editorial Staff
September 10, 2026
Earth Science Tech Reports $35.7M Revenue and Debt-Free Balance Sheet
TLDR
- Earth Science Tech grew FY2026 revenue to $35.7 million while reducing debt and funding growth internally, offering a competitive edge.
- Earth Science Tech integrates compounding pharmacy, telemedicine, clinical support, and fulfillment through subsidiaries, creating a vertically integrated healthcare platform with B2B and B2C revenue streams.
- Earth Science Tech improves healthcare access by connecting patients to customized medications through telemedicine and direct fulfillment, making care more convenient.
- Earth Science Tech fully repaid long-term debt and expects operating cash flow to cover FY2027 needs without dilutive financing.
Impact - Why it Matters
This news matters because it demonstrates that Earth Science Tech has achieved significant revenue growth while simultaneously strengthening its financial position. The ability to generate positive operating cash flow and fully repay long-term debt without resorting to dilutive financing is a notable milestone for a small-cap healthcare company. It suggests that ETST's vertically integrated model is not only gaining traction but also becoming financially self-sustaining, which could reduce risk for investors and provide a foundation for future expansion. As the company continues to build out its telemedicine and compounding pharmacy platform, its success may signal broader opportunities in the direct-to-patient healthcare space.
Summary
Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, which together combine compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. This B2B and B2C model allows ETST to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across both physical and digital healthcare operations. The company's core value proposition is the seamless integration of patient care from consultation to fulfillment, achieved through the synergy of its specialized subsidiaries.
In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024. The company also reported positive operating cash flow and a stronger balance sheet, reducing total liabilities from $3.146 million to $1.928 million, increasing assets from $7.066 million to $8.969 million, and fully repaying its long-term debt. ETST expects operating cash flow to fund its FY2027 needs without additional dilutive financing, highlighting a strategy of pursuing growth through internally generated cash rather than debt or shareholder dilution.
To view the full article, visit https://nnw.fm/oJY5L. For more information about Earth Science Tech, please visit www.EarthScienceTech.com. The latest news and updates relating to ETST are available in the company's newsroom at https://nnw.fm/ETST. This release is distributed by NetworkNewsWire ("NNW"), a specialized communications platform focused on financial news and content distribution. NNW is part of the Dynamic Brand Portfolio @ IBN, which delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Reports $35.7M Revenue and Debt-Free Balance Sheet
